Latest Profitability News

RPM Automotive Group has launched a fully operational tyre recycling plant, boosting its earnings potential while reporting steady revenue and improved profitability for the nine months FYTD.

Ventia Services Group Limited delivered strong financial results for 2024, highlighted by a 12.8% rise in NPATA and a record 92% contract renewal rate, while reaffirming growth guidance despite ongoing ACCC proceedings.

GQG Partners reported robust financial results for 2024 with significant growth in funds under management and earnings, underscoring its adaptability and alignment with shareholders. The 2025 Annual Meeting confirmed strong investor confidence with near-unanimous director re-election.

New Frontier Minerals advances its NWQ Copper Project by securing bulk sample processing at Austral Resources’ Mt Kelly plant, accelerating its path to copper production in Queensland’s Mt Isa Copper Belt.

Australian Agricultural Company Limited (AACo) reported a 14% rise in operating profit to $58.4 million for FY25, driven by increased sales volumes and disciplined cost control despite challenging market conditions. The company also marked a significant reduction in statutory loss, signaling improved financial resilience.

Australian Agricultural Company Limited (AACo) reported a robust FY25 operating profit of $58.4 million, driven by increased meat and cattle sales volumes and strategic brand growth despite inflationary pressures.

Australian Agricultural Company Limited (AACo) has reported a robust turnaround in its FY25 results, with significant gains in revenue and profitability driven by higher sales volumes and improved operational efficiency.

Oceania Healthcare reported a 4.1% rise in underlying EBITDA for FY25, driven by strong sales and operational improvements, while launching a new strategic plan focused on growth and efficiency.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.

AFT Pharmaceuticals reported a 6% increase in revenue to NZ$208 million for the year ending March 2025, but net profit fell 23%, prompting a modest final dividend declaration.

Smart Parking Limited reports robust H1 FY25 growth driven by a strategic US acquisition and expanding global footprint, underpinned by proprietary AI technology.